Dp. Nicolau et al., Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, INT J ANT A, 11(2), 1999, pp. 159-161
Previous studies in our laboratory have shown that antiplatelet agents, asp
irin and ticlopidine, in clinically relevant concentrations influence the d
evelopment and treatment of experimental endocarditis. To study the influen
ce of combination antiplatelet treatment on the development of aortic veget
ations, infected animals received either aspirin alone, ticlopidine alone,
aspirin plus ticlopidine or no antiplatelet therapy. The combination antipl
atelet treated group had a statistically significant (P = 0.043) reduction
of the vegetative weight as compared with the untreated controls. While bot
h the single antiplatelet agent groups showed a reduction in the size of th
e vegetation, neither achieved statistical significance. None of the treatm
ent groups significantly altered the bacterial density relative to untreate
d controls. These findings reveal that the combination of aspirin and ticlo
pidine, two potent inhibitors of platelet aggregation with different mechan
isms of action, act synergistically to optimally reduce the weight of aorti
c valve vegetations. (C) 1999 Published by Elsevier Science B.V. and Intern
ational Society of Chemotherapy. All rights reserved.